loadpatents
Patent applications and USPTO patent grants for Pochon; Sibylle.The latest application filed is for "targeting vector-phospholipid conjugates".
Patent | Date |
---|---|
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy Grant 9,446,155 - Sato , et al. September 20, 2 | 2016-09-20 |
Targeting Vector-phospholipid Conjugates App 20160263254 - BUSSAT; Philippe ;   et al. | 2016-09-15 |
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy Grant 9,408,926 - Arbogast , et al. August 9, 2 | 2016-08-09 |
Targeting vector-phospholipid conjugates Grant 9,381,258 - Bussat , et al. July 5, 2 | 2016-07-05 |
Targeting vector-phospholipid conjugates Grant 9,295,737 - Bussat , et al. March 29, 2 | 2016-03-29 |
Kdr And Vegf/kdr Binding Peptides And Their Use In Diagnosis And Therapy App 20140286864 - SATO; AARON K. ;   et al. | 2014-09-25 |
Targeting Vector-phospholipid Conjugates App 20140206837 - Bussat; Philippe ;   et al. | 2014-07-24 |
Kdr And Vegf/kdr Binding Peptides And Their Use In Diagnosis And Therapy App 20140161732 - ARBOGAST; Christophe ;   et al. | 2014-06-12 |
Multivalent constructs for therapeutic and diagnostic applications Grant 8,663,603 - Arbogast , et al. March 4, 2 | 2014-03-04 |
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy Grant 8,642,010 - Sato , et al. February 4, 2 | 2014-02-04 |
Targeting Vector-phospholipid Conjugates App 20140031520 - BUSSAT; Philippe ;   et al. | 2014-01-30 |
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy Grant 8,623,822 - Arbogast , et al. January 7, 2 | 2014-01-07 |
Targeting Vector-phospholipid Conjugates App 20130266519 - BUSSAT; PHILIPPE ;   et al. | 2013-10-10 |
Targeting vector-phospholipid conjugates Grant 8,551,450 - Bussat , et al. October 8, 2 | 2013-10-08 |
Fibrin-binding peptides and conjugates thereof Grant 8,466,107 - Bussat , et al. June 18, 2 | 2013-06-18 |
Fibrin-Binding Peptides and Conjugates Thereof App 20120328512 - Bussat; Philippe ;   et al. | 2012-12-27 |
Targeting and therapeutic compounds and gas-filled microvesicles comprising said compounds Grant 8,293,214 - Swenson , et al. October 23, 2 | 2012-10-23 |
Fibrin-binding peptides and conjugates thereof Grant 8,278,274 - Bussat , et al. October 2, 2 | 2012-10-02 |
Targeting Vector-phospholipid Conjugates App 20110286936 - BUSSAT; Philippe ;   et al. | 2011-11-24 |
Targeting vector-phospholipid conjugates Grant 7,985,402 - Bussat , et al. July 26, 2 | 2011-07-26 |
Kdr And Vegf/kdr Binding Peptides And Their Use In Diagnosis And Therapy App 20110097275 - Arbogast; Christophe ;   et al. | 2011-04-28 |
Multivalent Constructs For Therapeutic And Diagnostic Applications App 20110070165 - Arbogast; Christophe ;   et al. | 2011-03-24 |
Multivalent constructs for therapeutic and diagnostic applications Grant 7,910,088 - Arbogast , et al. March 22, 2 | 2011-03-22 |
Multivalent constructs for therapeutic and diagnostic applications Grant 7,854,919 - Arbogast , et al. December 21, 2 | 2010-12-21 |
Medical imaging system based on a targeted contrast agent Grant 7,846,100 - Gaud , et al. December 7, 2 | 2010-12-07 |
Targeting Vector-phospholipid Conjugates App 20100233090 - Bussat; Philippe ;   et al. | 2010-09-16 |
Targeting vector-phospholipid conjugates Grant 7,794,693 - Bussat , et al. September 14, 2 | 2010-09-14 |
Fibrin-Binding Peptides and Conjugates Thereof App 20100158814 - Bussat; Philippe ;   et al. | 2010-06-24 |
Targeting And Therapeutic Compounds And Gas-filled Microvesicles Comprising Said Compounds App 20100008863 - Swenson; Rolf E. ;   et al. | 2010-01-14 |
Kdr And Vegf/kdr Binding Peptides And Their Use In Diagnosis And Therapy App 20100003195 - Sato; Aaron K. ;   et al. | 2010-01-07 |
Targeting Vector-phospholipid Conjugates App 20090131636 - Bussat; Philippe ;   et al. | 2009-05-21 |
Targeting Vector-phospholipid Conjugates App 20080152594 - Bussat; Philippe ;   et al. | 2008-06-26 |
Medical Imaging System Based on a Targeted Contrast Agent App 20080139942 - Gaud; Emmanuel ;   et al. | 2008-06-12 |
Targeting Vector-phospholipid Conjugates App 20080107607 - Bussat; Philippe ;   et al. | 2008-05-08 |
Multivalent Constructs For Therapeutic And Diagnostic Applications App 20070243139 - Arbogast; Christophe ;   et al. | 2007-10-18 |
Multivalent constructs for therapeutic and diagnostic applications Grant 7,261,876 - Arbogast , et al. August 28, 2 | 2007-08-28 |
Multivalent Constructs For Therapeutic And Diagnostic Applications App 20070172428 - Arbogast; Christophe ;   et al. | 2007-07-26 |
KDR and VEGF/KDR binding peptides App 20050250700 - Sato, Aaron K. ;   et al. | 2005-11-10 |
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy App 20050100963 - Sato, Aaron K. ;   et al. | 2005-05-12 |
Multivalent constructs for therapeutic and diagnostic applications App 20050027105 - Arbogast, Christophe ;   et al. | 2005-02-03 |
Multivalent constructs for therapeutic and diagnostic applications App 20040210041 - Arbogast, Christophe ;   et al. | 2004-10-21 |
Multivalent constructs for therapeutic and diagnostic applications App 20040018974 - Arbogast, Christophe ;   et al. | 2004-01-29 |
Amphiphilic linkers for coupling administrable diagnostically or physiologically active agents and bioselective targeting compounds Grant 5,910,300 - Tournier , et al. June 8, 1 | 1999-06-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.